143
Participants
Start Date
January 31, 2007
Primary Completion Date
February 28, 2010
Study Completion Date
March 31, 2011
EndoTAG-1 + paclitaxel
EndoTAG-1 22 mg/m² + Paclitaxel 70 mg/m² weekly
EndoTAG-1
EndoTAG-1 44 mg/m² twice weekly
Paclitaxel
Paclitaxel 90 mg/m² weekly
Institut Jules Bordet - Centre des Tumeurs de l'Université Libre de Bruxelles, Brussels
CHU Brugmann, Brussels
UZ Antwerpen, Edegem
CHU Liège, Liège
Centre Oscar Lambret, Lille
Cente Antoine Lacassagne, Nice
Institut Curie, Paris
Hôpital de Jour Centre Henri Kaplan, Tours
Institut Gustave Roussy, Villejuif
Vedanta Institute of Medical Science, Ahmedabad
Bangalore Institute of Oncology, Bangalore
Searoc Cancer Center, Jaipur
Lakeshore Hospital, Kochi
Deenanath Mangeshkar Hospital, Pune
Kaushalya Medical Foundation, Thāne
Wojewodzkie Centrum Onkologii, Gdansk
Centrum Onkologii Instytut im. M. Sklodowskiej-Curie, Gliwice
Instytut im. M. Sklodowskiej-Curie, Lublin
NZOZ Grupowa Specjalistyczna, Olsztyn
Klinika Onkologii Adadmii Medycznej, Poznan
"Institute of Oncology Prof. Dr. Al. Trestioreanu", Bucharest
"Institute of Oncology Prof. Dr. I. Chiricuta", Cluj-Napoca
Center of Medical Oncology, Iași
Emergency County Hospital Sibiu, Sibiu
"Oncology Clinic Oncomed", Timișoara
Dnepropetrovsk State Medical Acedamy, Dnipro
Institute of Medical Radiology of Acedamy of Medical Sciences, Kharkiv
Department of Abdominal Surgery, Kiev
Institut of Oncology, Kiev
Surgical Department, Kiev
Rivne Regional Oncological Dispensary, Rivne
Sumy Reginal Oncology Center, Sumy
Regional Clinical Oncological Dispensary, Uzhhorod
Lead Sponsor
MediGene
INDUSTRY